Vaccinex Inc is a biotechnology company focused on the discovery and development of innovative therapeutic solutions for cancer and neurodegenerative diseases

Utilizing its proprietary monoclonal antibody platform, the company aims to harness the power of the immune system to create treatments that can target and eliminate tumor cells or modulate neuroinflammatory processes. Vaccinex is engaged in advancing its pipeline of drug candidates through various stages of clinical trials, with the goal of improving patient outcomes and quality of life. The company is committed to scientific excellence and collaboration in the biotechnology field to drive breakthroughs in medicine.